Archive for the ‘Dermatology’ Category
Wednesday, July 9th, 2008
VioQuest Pharmaceuticals (OTCBB: VOQP) announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA). The application seeks marketing clearance for Xyfid™ (1% uracil topical), a topical skin preparation intended to relieve and to manage the burning and itching associated with various dermatoses including atopic ...
Posted in Dermatology | No Comments »
Thursday, July 3rd, 2008
Scientists from Hungary, Germany and the U.K. have discovered that our own body not only makes chemical compounds similar to the active ingredient in marijuana (THC), but these play an important part in maintaining healthy skin. This finding on "endocannabinoids" just published online in, and scheduled for the October 2008 ...
Posted in Dermatology | No Comments »
Thursday, July 3rd, 2008
The U.S. Food and Drug Administration ("FDA") announced the approval of EVOLENCE® for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE® is a new advanced collagen-based structural dermal filler, and a first of its kind product. The introduction of EVOLENCE® marks the first ...
Posted in Dermatology | No Comments »
Thursday, July 3rd, 2008
Sunscreen has become a daily necessity for anyone spending time outdoors in the sun, especially during the hot summer months. Yet, very few people consider the protection afforded to them from their clothing. Clothing does protect the skin against the sun's harmful ultraviolet rays, but not all clothing provides ...
Posted in Dermatology | No Comments »
Wednesday, July 2nd, 2008
HUMIRA (adalimumab) has today been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for adults with severe chronic plaque psoriasis.1 Adalimumab is the only fully human anti-TNF (tumour necrosis factor) monoclonal antibody licensed for the treatment of plaque psoriasis in the UK. ...
Posted in Dermatology | No Comments »
Tuesday, July 1st, 2008
For many of us the summer is a time to think about taking a break, enjoying long hot days in the sun, sitting on a beach or swimming in the sea. But for people living with a skin disease called ...
Posted in Dermatology | No Comments »
Tuesday, July 1st, 2008
The National Institute for Health and Clinical Excellence (NICE) has published guidance on the use of adalimumab for the treatment of psoriasis in adults. Adalimumab is recommended as a possible treatment for adults with plaque psoriasis only if: - their condition is severe and- their condition has not improved with ...
Posted in Dermatology | No Comments »
Thursday, June 26th, 2008
Unexplained skin irritations, itchy rashes it happens to millions of Americans and many say they have no idea what causes the breakouts. According to experts jewelry allergies are not only extremely common, but very simple to prevent."We see it quite frequently," says Lisa Garner, M.D., dermatologist on the medical staff ...
Posted in Dermatology | No Comments »
Friday, June 20th, 2008
As the thermometer rises, so does the humidity. For many, the humidity can be annoying, but for the nearly 8 million Americans who suffer from a treatable condition called hyperhidrosis(1), or excessive sweating, the humidity can be unbearable. Hyperhidrosis affects underarms, palms, feet and head, among other areas, and though ...
Posted in Dermatology | No Comments »
Sunday, June 15th, 2008
The arrival of summer brings with it an alarming increase of honey bees, wasps, yellow jackets and hornets, especially dreadful for those who experience severe allergic reactions to insect venom.Many who have reactions like hives, breathing difficulty, coughing or a drop in blood pressure are unaware that Epipens, self-injected epinephrine, ...
Posted in Dermatology | No Comments »
Saturday, June 14th, 2008
A study published on http://www.bmj.com highlights the need for people to be aware of the possible health risks associated with body piercing. The study, carried out by experts at the Health Protection Agency and the London School of Hygiene and Tropical Medicine, looked at the prevalence of cosmetic body piercing, ...
Posted in Dermatology | No Comments »
Tuesday, June 10th, 2008
BioTrends Research Group, Inc. released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis. This report is based on responses to an online survey completed by 102 US Dermatologists in April 2008. According to the study, the majority of Dermatologists reported ...
Posted in Dermatology | No Comments »
Saturday, June 7th, 2008
Allergan, Inc. (NYSE:AGN) announced that it intends to file a New Drug Application by end of the third quarter of 2008 with the U.S. Food and Drug Administration (FDA) for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth. Allergan has completed its clinical trial program demonstrating ...
Posted in Dermatology | No Comments »
Thursday, May 29th, 2008
A review of data based on ten years of experience using efalizumab (Raptiva®) to treat chronic plaque psoriasis confirms that that the drug has a favorable long-term safety profile. The chronic plaque form of psoriasis accounts for about 75 percent of psoriasis cases. The new findings, reported at the 5th ...
Posted in Dermatology | No Comments »
Wednesday, May 28th, 2008
Lutronic has announced that it has received FDA clearance to market its Spectra VRM III. This dual pulse Q-Switched Nd:Yag laser is the feature-rich successor to the Spectra VRM II. The laser produces 4 wavelengths (1064 nm, 532 nm, 585 nm, ...
Posted in Dermatology | No Comments »
